About this trial
A non-sponsored prospective randomized single-blind national multicenter interventional study which aims to compare the diagnostic accuracy between US-guided percutaneous lung needle biopsies and CT-guided in peripheral lung lesions. Secondary endpoints are:
* onset of number and type of complications during and after the procedure, within the first three hour; * exposition to ionizing radiation, in milligray(mGy); * patient comfort during the procedure; * duration of the procedure,
Eligibility criteria
Qualifiers
Willingness and ability to provide free and informed consent. Age older then 18 years old.
Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing
Disqualifiers
Inability to provide free and informed consent, in the absence of an available legal guardian.
Age younger then 18 years old.
Terminal neoplastic diseases/ palliative care patients.
Patients with one lung, anatomical of functional.
Trial design
Treatments tested in this trial
- US-GUIDED PERCUTANEOUS LUNG NEEDLE BIOPSY
- CT-GUIDED PERCUTANEOUS LUNG NEEDLE BIOPSY